financetom
Business
financetom
/
Business
/
Sundaram Home Finance revises interest rates for fifth time this fiscal year
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sundaram Home Finance revises interest rates for fifth time this fiscal year
Jan 26, 2023 4:19 AM

Sundaram Home Finance has revised its interest rates on fixed deposits for the fifth time in the current financial year. The revisions are effective from February 1.

For senior citizens, rates on two-year deposits have been revised higher by 50 basis points to 8 percent per annum. For one and three-year deposits, interest rates have been raised to 7.7 percent and 8 percent respectively.

The company has revised the interest rates for trusts to 7.2 percent, 7.5 percent and 8 percent for one, two, and three-year deposits respectively.

Individual interest rates have been raised to 7.2 percent for one-year and 7.5 percent per annum for two and three-year deposits.

The interest rates on four- and five-year deposits remain unchanged.

Sundaram Home Finance registered a net profit of Rs 97.5 crore on disbursements of Rs 1,740 crore in the first half of this year.

Sundaram Home Finance, a wholly owned subsidiary of Sundaram Finance Ltd, is a leading player in the housing finance sector. It offers home loans, plot loans, home improvement & extension loans, and loans against property.

(Edited by : Rukmani Krishna)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rocket Doctor AI in Q2 Produces First
Rocket Doctor AI in Q2 Produces First "Significant" Quarterly Revenue
Aug 29, 2025
09:27 AM EDT, 08/29/2025 (MT Newswires) -- Rocket Doctor AI ( TREIF ) on Friday reported its first significant revenue producing quarter as its net loss narrowed. For the three-months ended June 30, the net comprehensive loss declined to $2.68 million or $0.04 per share, compared with $2.72 million or $0.07 per share, a year earlier. Revenue for the quarter...
Update: Market Chatter: CVS Health Defers Offering COVID-19 Vaccines in 16 States
Update: Market Chatter: CVS Health Defers Offering COVID-19 Vaccines in 16 States
Aug 29, 2025
09:27 AM EDT, 08/29/2025 (MT Newswires) -- (Updates with spokesperson statement in the fourth and fifth paragraphs.) CVS Health ( CVS ) is currently holding off on offering COVID-19 vaccines in 16 states due to the current regulatory environment, The New York Times reported Friday, citing company spokesperson Amy Thibault. The company is waiting until the Advisory Committee on Immunization...
ISS recommends TaskUs investors reject proposed deal to take company private
ISS recommends TaskUs investors reject proposed deal to take company private
Aug 29, 2025
NEW YORK, Aug 28 (Reuters) - Institutional Shareholder Services on Thursday urged TaskUs ( TASK ) investors to reject a plan proposed by investment firm Blackstone and TaskUs' ( TASK ) co-founders to take the outsourcing company that handles content moderation private. There does not appear to be a compelling reason to accept the terms, the influential proxy advisory firm...
DuPont Divests Aramids Business In $1.8 Billion Deal To Sharpen Portfolio
DuPont Divests Aramids Business In $1.8 Billion Deal To Sharpen Portfolio
Aug 29, 2025
DuPont de Nemours, Inc. ( DD ) said Friday it agreed to sell its Aramids business, including the Kevlar and Nomex brands, to Arclin, a portfolio company of TJC, L.P., in a deal valued at about $1.8 billion. The transaction is expected to close in the first quarter of 2026, pending regulatory approvals. At closing, DuPont ( DD ) will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved